Latest Kaiser Health News Stories
Vapers Accuse Officials Of Overreach As Investigation Into Deadly Lung Illness Lags
With federal authorities offering few details about what is causing the deadly outbreak of vaping-related lung illnesses, vaping advocates are crafting an alternative narrative reverberating through online communities.
Skin-Lightening Cream Put A Woman Into A Coma. It Could Happen Again.
A Sacramento woman is in a coma after using a face cream from Mexico. It is the nation’s first case of methylmercury poisoning from a cosmetic, and public health officials can do almost nothing to prevent other contaminated cosmetics from hitting the shelves.
At Raucous Hearing, No Unity On Vaping Issues
A hearing before a House Oversight and Reform Committee panel on how to address the crisis of respiratory injuries related to vaping turned surprisingly partisan.
As Off-Label Use Spreads, Supplies Of Niche Drugs And Patients’ Patience Grow Short
The reasons behind one particular shortage of a therapy known as IVIG are complicated, stemming from increased demand and the medication’s long production window.
Camouflaged Vaping Devices Are Hoodwinking Parents And Schools
The vaping hoodie. The vaping watch. The vaping phone case. Each ready to deliver a puff of nicotine (or marijuana) anywhere, anytime. The vaping market is crowded with sleek, camouflaged devices that have teachers and parents struggling to monitor illicit usage of a product that has surged in popularity among high schoolers.
Longtime Crusader Against OxyContin Begins To See The Fruits Of Her Struggle
Barbara Van Rooyan lost her son to the drug 15 years ago and has fought ceaselessly since then to hold Purdue Pharma accountable for its role in the opioid crisis.
Purveyors Of Black-Market Pharmaceuticals Target Immigrants
Illegal medications, sold in immigrant communities around the United States, can cause serious harm to consumers, authorities say. Law enforcement officers are cracking down, but some think more must be done.
Vapers Seek Relief From Nicotine Addiction In — Wait For It — Cigarettes
Even though e-cigarette makers market their products as a safer alternative to cigarettes, a growing number of vapers are trying to quit— and they’re turning to cigarettes to help them.
KHN’s ‘What The Health?’: Despite Booming Economy, Uninsured Rate Ticks Up
Nearly 2 million more Americans were uninsured in 2018 than in the previous year, according to the Census Bureau’s annual report. Plus, the Trump administration announced plans to ban flavored vape liquids, and Congress is back and working to address high prescription drug prices and “surprise” medical bills. This week, Joanne Kenen of Politico, Tami Luhby of CNN and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.
Mysterious Vaping Lung Injuries May Have Flown Under Regulatory Radar
Doctors who saw patients with a mysterious lung illness in the past suspected vaping as the cause but didn’t know where to report such cases.
Shopping Abroad For Cheaper Medication? Here’s What You Need To Know
Americans routinely skirt federal law by crossing into Canada and Mexico or tapping online pharmacies abroad to purchase prescription medications at a fraction of the price they would pay at home. Is it safe? Not necessarily. Here’s some advice.
DIY Tech Gives People More Freedom In Managing Diabetes
People with diabetes say they’ve been waiting for years for better technology to manage their chronic condition. Tired of waiting, some tech-savvy, do-it-yourselfers are constructing their own devices using open-source programming instructions.
KHN filed multiple Freedom of Information Act requests over months, and the FDA responded Wednesday saying the data about device malfunctions is now publicly available online.
Five Things We Found In The FDA’s Hidden Device Database
The Food and Drug Administration released two decades of previously hidden data containing millions of injuries or malfunctions by medical devices. Here’s what we’ve learned so far.
FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine
In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
More Than Half Of Surgical Stapler Malfunctions Went To Hidden FDA Database
The FDA reveals that 56,000 malfunctions associated with surgical staplers weren’t reported through its traditional public reporting system.
Hidden Reports Masked The Scope Of Widespread Harm From Faulty Heart Device
The Food and Drug Administration allowed one company to send 50,000 reports of harm or malfunctions to an internal database even as patients worried about faulty defibrillators lodged in their hearts.
Price Check On Drug Ads: Would Revealing Costs Help Patients Control Spending?
As part of his plan to tamp down drug pricing, President Donald Trump wants pharmaceutical companies to provide cost information in drug ads — just like side effects.
FDA To End Program That Hid Millions Of Reports On Faulty Medical Devices
In the wake of a KHN investigation, the agency will no longer let device makers file reports of harm outside a widely used public database.
